India's 20 largest drug manufacturers are forecast to boost their plant investments by 40% by 2017-18, to more than Rs 50,000 crore ($8.3 billion), as they look to improve quality and chase new patent expirations. The forecast, from an Indian trade agency, comes as a number of India's biggest drugmakers have suffered plant bans and received warnings from the FDA about poor quality. Report | More